Hyperprolactinemia and galactorrhea with standard-dose famotidine therapy

Ann Pharmacother. 1995 Jul-Aug;29(7-8):788. doi: 10.1177/106002809502907-827.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Ulcer Agents / adverse effects*
  • Anti-Ulcer Agents / therapeutic use
  • Duodenal Ulcer / drug therapy
  • Famotidine / adverse effects*
  • Famotidine / therapeutic use
  • Female
  • Galactorrhea / chemically induced*
  • Humans
  • Hyperprolactinemia / chemically induced*

Substances

  • Anti-Ulcer Agents
  • Famotidine